Literature DB >> 12834436

Neuropeptide y targets in the hypothalamus: nitric oxide synthesizing neurones express Y1 receptor.

S O Fetissov1, Z-Q Xu, L C Byrne, H Hassani, P Ernfors, T Hökfelt.   

Abstract

Neuropeptide Y (NPY)-expressing neurones in the arcuate nucleus densely innervate many hypothalamic nuclei. To determine the neurochemical phenotype of target neurones for NPY, we studied the immunohistochemical localization of the NPY Y1 receptor (Y1R) in discrete subpopulations of neurones in the rat hypothalamus. Among several tested populations, including hypocretin/orexin-, melanin-concentrating hormone (MCH)- and nitric oxide synthase (NOS)-positive neurones, only the latter were found to coexpress the Y1R. Numerous Y1R/NOS-positive neurones were found as a densely packaged group of cells located ventrolateral to the ventromedial nucleus, forming a band ascending towards the fornix. Lower numbers of Y1R/NOS-positive neurones were found in the perifornical area and in the peri- and paraventricular nuclei. Expression of the Y1R gene was found in the same locations in the mouse by colocalizing beta-galactosidase, a Y1R gene reporter, with NOS in a Y1R knockout mouse. To explore possible downstream targets of NO in the rat hypothalamus, the NO-regulated molecule cGMP was analysed immunohistochemically after incubation of brain slices with sodium nitroprusside, an NO donor. We observed several cGMP-positive cell bodies in the arcuate nucleus, cGMP-positive blood vessels and a cGMP-positive network of thin fibres, some of which colocalized with choline acetyltransferase.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12834436     DOI: 10.1046/j.1365-2826.2003.01051.x

Source DB:  PubMed          Journal:  J Neuroendocrinol        ISSN: 0953-8194            Impact factor:   3.627


  8 in total

1.  Huntingtin-associated protein 1 regulates postnatal neurogenesis and neurotrophin receptor sorting.

Authors:  Jianxing Xiang; Hao Yang; Ting Zhao; Miao Sun; Xingshun Xu; Xin-Fu Zhou; Shi-Hua Li; Xiao-Jiang Li
Journal:  J Clin Invest       Date:  2013-12-20       Impact factor: 14.808

2.  Central hypotensive effects of neuropeptide Y are modulated by endothelial nitric oxide synthase after activation by ribosomal protein S6 kinase.

Authors:  Pei-Wen Cheng; Alexander T H Wu; Pei-Jung Lu; Ya-Chun Yang; Wen-Yu Ho; Hui-Ching Lin; Michael Hsiao; Ching-Jiunn Tseng
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

Review 3.  Controlling feeding behavior by chemical or gene-directed targeting in the brain: what's so spatial about our methods?

Authors:  Arshad M Khan
Journal:  Front Neurosci       Date:  2013-12-18       Impact factor: 4.677

4.  Systemic but not central nervous system nitric oxide synthase inhibition exacerbates the hypertensive effects of chronic melanocortin-3/4 receptor activation.

Authors:  Jussara M do Carmo; Mirian Bassi; Alexandre A da Silva; John E Hall
Journal:  Hypertension       Date:  2011-01-24       Impact factor: 10.190

5.  Ghrelin enhances food intake and carbohydrate oxidation in a nitric oxide dependent manner.

Authors:  Shayan Abtahi; Aaisha Mirza; Erin Howell; Paul J Currie
Journal:  Gen Comp Endocrinol       Date:  2017-05-26       Impact factor: 2.822

6.  The regulation of veratridine-stimulated electrogenic ion transport in mouse colon by neuropeptide Y (NPY), Y1 and Y2 receptors.

Authors:  Niall P Hyland; Helen M Cox
Journal:  Br J Pharmacol       Date:  2005-11       Impact factor: 8.739

7.  Efferent projections of neuropeptide Y-expressing neurons of the dorsomedial hypothalamus in chronic hyperphagic models.

Authors:  Shin J Lee; Melissa Kirigiti; Sarah R Lindsley; Alberto Loche; Christopher J Madden; Shaun F Morrison; M Susan Smith; Kevin L Grove
Journal:  J Comp Neurol       Date:  2013-06-01       Impact factor: 3.215

8.  Neuromodulation of bone: Role of different peptides and their interactions (Review).

Authors:  Xiaoyu Wang; Jia Xu; Qinglin Kang
Journal:  Mol Med Rep       Date:  2020-11-12       Impact factor: 2.952

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.